GSK restructures bonuses for reps

Share this article:
Beginning in 2011, GlaxoSmithKline will reward its sales reps for the relationships they forge with doctors, instead of the amount of drugs they sell.  

Under the new plan, bonuses will be awarded based on “new tools [in development] to evaluate the performance of sales professionals,” which include customer evaluations, according to Kevin Colgan, a GSK spokesperson. Bonuses will no longer be based on the “individual achievement of sales targets,” said Colgan.

Robert Nauman, principal at BioPharma Advisers and a former GSK marketing director, said the decision reflects the shift of purchasing power away from individual physicians, and toward managed care directors and office managers. “There's less and less value in a rep visit,” said Nauman. “Reps now exist to support physicians, and provide them with relevant information faster than they can get it elsewhere”—an admittedly formidable task, Nauman said.

GSK will also streamline account management, according to Colgan. “Rather than having multiple sales professionals calling on providers…we are moving to a model in which a single individual is now responsible for managing that account and bringing specialists from within the company to meet specific customer requests and needs,” he said.
Share this article:

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"